WASHINGTON (Reuters) - U.S. President Donald Trump on Monday renewed his criticism against drugmakers over medicine prices and vowed action, but gave no other details about his long-touted plan to address price hikes.
Trump had vowed in May that drug companies would soon be slashing prices. During his presidential campaign, he promised lower U.S. drug costs, but prices remain high.
"Pfizer & others should be ashamed that they have raised drug prices for no reason." Trump wrote in a post on Twitter on Monday. "We will respond!"
(Reporting by Susan Heavey; Editing by David Gregorio)
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app